Using proteomics to identify potential therapeutic targets in platelets

被引：15
作者：
Maguire, FB [1 ]
Foy, M [1 ]
Fitzgerald, DJ [1 ]
机构：
[1] Univ Coll Dublin, Conway Inst, Dept Mol Med, Dublin 4, Ireland
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2005年 / 33卷
关键词：
MS; membrane lipid raft; platelet phosphoproteome; platelet releasate; platelet; proteomics;
D O I：
10.1042/BST0330409
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Proteomics has provided powerful new insights into the complex events of the anucleate platelet and has revealed many potential protein targets in the search for suitable agents for thrombotic disease. in the present study, we summarize recent proteomic approaches to analyse specific platelet subproteomes, such as the platelet releasate, the platelet phosphotyrosine proteome and characterization of the proteins associated with membrane lipid rafts.
引用
收藏
页码：409 / 412
页数：4
相关论文
共 50 条
  • [1] Platelet proteomics: Identification of potential therapeutic targets
    Maguire, PB
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) : 481 - 486
  • [2] Proteomics identifies new potential therapeutic targets of diabetic retinopathy
    Zhou, Huanran
    Xu, Qian
    Li, Hongxue
    Hu, Yuxin
    Kuang, Hongyu
    BIOENGINEERED, 2022, 13 (04) : 9916 - 9927
  • [3] Using proteomics to identify ubiquitin ligase–substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases
    Stephanie L. Rayner
    Marco Morsch
    Mark P. Molloy
    Bingyang Shi
    Roger Chung
    Albert Lee
    Cellular and Molecular Life Sciences, 2019, 76 : 2499 - 2510
  • [4] Using Omics to Identify Novel Therapeutic Targets in Heart Failure
    Lteif, Christelle
    Huang, Yimei
    Guerra, Leonardo A.
    Gawronski, Brian E.
    Duarte, Julio D.
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2024, 17 (03): : 277 - 293
  • [5] Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
    Henry, Albert
    Gordillo-Maranon, Maria
    Finan, Chris
    Schmidt, Amand F.
    Ferreira, Joao Pedro
    Karra, Ravi
    Sundstrom, Johan
    Lind, Lars
    Arnlov, Johan
    Zannad, Faiez
    Malarstig, Anders
    Hingorani, Aroon D.
    Lumbers, R. Thomas
    CIRCULATION, 2022, 145 (16) : 1205 - 1217
  • [6] Using proteomics to identify ubiquitin ligase-substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases
    Rayner, Stephanie L.
    Morsch, Marco
    Molloy, Mark P.
    Shi, Bingyang
    Chung, Roger
    Lee, Albert
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (13) : 2499 - 2510
  • [7] The application of proteomics technology to thrombosis research: the identification of potential therapeutic targets in cardiovascular disease
    Howes, Joanna-Marie
    Keen, Jeff N.
    Findlay, John B. C.
    Carter, Angela M.
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (03) : 205 - 212
  • [8] Development and Evaluation of Antibody Proteomics Technology for Rapid and Comprehensive Identification of Potential Biomarkers and Therapeutic Targets
    Nagano, Kazuya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2018, 41 (05) : 663 - 669
  • [9] Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy
    MacMullan, Melanie A.
    Dunn, Zachary S.
    Graham, Nicolas
    Yang, Lili
    Wang, Pin
    THERANOSTICS, 2019, 9 (25): : 7872 - 7888
  • [10] Proteomics in the discovery of new therapeutic targets for psychiatric disease
    Voshol, H
    Glucksman, MJ
    van Oostrum, J
    CURRENT MOLECULAR MEDICINE, 2003, 3 (05) : 447 - 458
12345